The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Quetiapine Fumarate API Market Research Report 2025
Synopsis
Quetiapine is an atypical antipsychotic approved for the treatment of schizophrenia, bipolar disorder, and along with an antidepressant to treat major depressive disorder.
The global Quetiapine Fumarate API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate API.
Report Scope
The Quetiapine Fumarate API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quetiapine Fumarate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quetiapine Fumarate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy’s
Tapi Teva
Tecoland
Aarti Industries
Hikal
Uquifa
Menadiona
Sumitomo Chemical
Zhejiang Suporpharm
Suanfarma Group
Sibram Pharmaceutical
Hinsun USA
Jubilant Pharma
Qilu Pharmaceutical
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Quetiapine Fumarate Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quetiapine Fumarate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Quetiapine Fumarate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Quetiapine Fumarate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Quetiapine is an atypical antipsychotic approved for the treatment of schizophrenia, bipolar disorder, and along with an antidepressant to treat major depressive disorder.
The global Quetiapine Fumarate API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate API.
Report Scope
The Quetiapine Fumarate API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quetiapine Fumarate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quetiapine Fumarate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy’s
Tapi Teva
Tecoland
Aarti Industries
Hikal
Uquifa
Menadiona
Sumitomo Chemical
Zhejiang Suporpharm
Suanfarma Group
Sibram Pharmaceutical
Hinsun USA
Jubilant Pharma
Qilu Pharmaceutical
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Quetiapine Fumarate Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quetiapine Fumarate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Quetiapine Fumarate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Quetiapine Fumarate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Quetiapine Fumarate API Market Overview
1.1 Product Definition
1.2 Quetiapine Fumarate API Segment by Type
1.2.1 Global Quetiapine Fumarate API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Quetiapine Fumarate API Segment by Application
1.3.1 Global Quetiapine Fumarate API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Quetiapine Fumarate Tablets
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Quetiapine Fumarate API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Quetiapine Fumarate API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Quetiapine Fumarate API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Quetiapine Fumarate API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Quetiapine Fumarate API Production Market Share by Manufacturers (2019-2024)
2.2 Global Quetiapine Fumarate API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Quetiapine Fumarate API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Quetiapine Fumarate API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Quetiapine Fumarate API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Quetiapine Fumarate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Quetiapine Fumarate API, Product Offered and Application
2.8 Global Key Manufacturers of Quetiapine Fumarate API, Date of Enter into This Industry
2.9 Quetiapine Fumarate API Market Competitive Situation and Trends
2.9.1 Quetiapine Fumarate API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Quetiapine Fumarate API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Quetiapine Fumarate API Production by Region
3.1 Global Quetiapine Fumarate API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Quetiapine Fumarate API Production Value by Region (2019-2030)
3.2.1 Global Quetiapine Fumarate API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Quetiapine Fumarate API by Region (2025-2030)
3.3 Global Quetiapine Fumarate API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Quetiapine Fumarate API Production by Region (2019-2030)
3.4.1 Global Quetiapine Fumarate API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Quetiapine Fumarate API by Region (2025-2030)
3.5 Global Quetiapine Fumarate API Market Price Analysis by Region (2019-2024)
3.6 Global Quetiapine Fumarate API Production and Value, Year-over-Year Growth
3.6.1 North America Quetiapine Fumarate API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Quetiapine Fumarate API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Quetiapine Fumarate API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Quetiapine Fumarate API Production Value Estimates and Forecasts (2019-2030)
4 Quetiapine Fumarate API Consumption by Region
4.1 Global Quetiapine Fumarate API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Quetiapine Fumarate API Consumption by Region (2019-2030)
4.2.1 Global Quetiapine Fumarate API Consumption by Region (2019-2024)
4.2.2 Global Quetiapine Fumarate API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Quetiapine Fumarate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Quetiapine Fumarate API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Quetiapine Fumarate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Quetiapine Fumarate API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Quetiapine Fumarate API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Quetiapine Fumarate API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Quetiapine Fumarate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Quetiapine Fumarate API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Quetiapine Fumarate API Production by Type (2019-2030)
5.1.1 Global Quetiapine Fumarate API Production by Type (2019-2024)
5.1.2 Global Quetiapine Fumarate API Production by Type (2025-2030)
5.1.3 Global Quetiapine Fumarate API Production Market Share by Type (2019-2030)
5.2 Global Quetiapine Fumarate API Production Value by Type (2019-2030)
5.2.1 Global Quetiapine Fumarate API Production Value by Type (2019-2024)
5.2.2 Global Quetiapine Fumarate API Production Value by Type (2025-2030)
5.2.3 Global Quetiapine Fumarate API Production Value Market Share by Type (2019-2030)
5.3 Global Quetiapine Fumarate API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Quetiapine Fumarate API Production by Application (2019-2030)
6.1.1 Global Quetiapine Fumarate API Production by Application (2019-2024)
6.1.2 Global Quetiapine Fumarate API Production by Application (2025-2030)
6.1.3 Global Quetiapine Fumarate API Production Market Share by Application (2019-2030)
6.2 Global Quetiapine Fumarate API Production Value by Application (2019-2030)
6.2.1 Global Quetiapine Fumarate API Production Value by Application (2019-2024)
6.2.2 Global Quetiapine Fumarate API Production Value by Application (2025-2030)
6.2.3 Global Quetiapine Fumarate API Production Value Market Share by Application (2019-2030)
6.3 Global Quetiapine Fumarate API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Dr. Reddy’s
7.1.1 Dr. Reddy’s Quetiapine Fumarate API Corporation Information
7.1.2 Dr. Reddy’s Quetiapine Fumarate API Product Portfolio
7.1.3 Dr. Reddy’s Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Dr. Reddy’s Main Business and Markets Served
7.1.5 Dr. Reddy’s Recent Developments/Updates
7.2 Tapi Teva
7.2.1 Tapi Teva Quetiapine Fumarate API Corporation Information
7.2.2 Tapi Teva Quetiapine Fumarate API Product Portfolio
7.2.3 Tapi Teva Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Tapi Teva Main Business and Markets Served
7.2.5 Tapi Teva Recent Developments/Updates
7.3 Tecoland
7.3.1 Tecoland Quetiapine Fumarate API Corporation Information
7.3.2 Tecoland Quetiapine Fumarate API Product Portfolio
7.3.3 Tecoland Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Tecoland Main Business and Markets Served
7.3.5 Tecoland Recent Developments/Updates
7.4 Aarti Industries
7.4.1 Aarti Industries Quetiapine Fumarate API Corporation Information
7.4.2 Aarti Industries Quetiapine Fumarate API Product Portfolio
7.4.3 Aarti Industries Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Aarti Industries Main Business and Markets Served
7.4.5 Aarti Industries Recent Developments/Updates
7.5 Hikal
7.5.1 Hikal Quetiapine Fumarate API Corporation Information
7.5.2 Hikal Quetiapine Fumarate API Product Portfolio
7.5.3 Hikal Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Hikal Main Business and Markets Served
7.5.5 Hikal Recent Developments/Updates
7.6 Uquifa
7.6.1 Uquifa Quetiapine Fumarate API Corporation Information
7.6.2 Uquifa Quetiapine Fumarate API Product Portfolio
7.6.3 Uquifa Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Uquifa Main Business and Markets Served
7.6.5 Uquifa Recent Developments/Updates
7.7 Menadiona
7.7.1 Menadiona Quetiapine Fumarate API Corporation Information
7.7.2 Menadiona Quetiapine Fumarate API Product Portfolio
7.7.3 Menadiona Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Menadiona Main Business and Markets Served
7.7.5 Menadiona Recent Developments/Updates
7.8 Sumitomo Chemical
7.8.1 Sumitomo Chemical Quetiapine Fumarate API Corporation Information
7.8.2 Sumitomo Chemical Quetiapine Fumarate API Product Portfolio
7.8.3 Sumitomo Chemical Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Sumitomo Chemical Main Business and Markets Served
7.7.5 Sumitomo Chemical Recent Developments/Updates
7.9 Zhejiang Suporpharm
7.9.1 Zhejiang Suporpharm Quetiapine Fumarate API Corporation Information
7.9.2 Zhejiang Suporpharm Quetiapine Fumarate API Product Portfolio
7.9.3 Zhejiang Suporpharm Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Zhejiang Suporpharm Main Business and Markets Served
7.9.5 Zhejiang Suporpharm Recent Developments/Updates
7.10 Suanfarma Group
7.10.1 Suanfarma Group Quetiapine Fumarate API Corporation Information
7.10.2 Suanfarma Group Quetiapine Fumarate API Product Portfolio
7.10.3 Suanfarma Group Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Suanfarma Group Main Business and Markets Served
7.10.5 Suanfarma Group Recent Developments/Updates
7.11 Sibram Pharmaceutical
7.11.1 Sibram Pharmaceutical Quetiapine Fumarate API Corporation Information
7.11.2 Sibram Pharmaceutical Quetiapine Fumarate API Product Portfolio
7.11.3 Sibram Pharmaceutical Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Sibram Pharmaceutical Main Business and Markets Served
7.11.5 Sibram Pharmaceutical Recent Developments/Updates
7.12 Hinsun USA
7.12.1 Hinsun USA Quetiapine Fumarate API Corporation Information
7.12.2 Hinsun USA Quetiapine Fumarate API Product Portfolio
7.12.3 Hinsun USA Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Hinsun USA Main Business and Markets Served
7.12.5 Hinsun USA Recent Developments/Updates
7.13 Jubilant Pharma
7.13.1 Jubilant Pharma Quetiapine Fumarate API Corporation Information
7.13.2 Jubilant Pharma Quetiapine Fumarate API Product Portfolio
7.13.3 Jubilant Pharma Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Jubilant Pharma Main Business and Markets Served
7.13.5 Jubilant Pharma Recent Developments/Updates
7.14 Qilu Pharmaceutical
7.14.1 Qilu Pharmaceutical Quetiapine Fumarate API Corporation Information
7.14.2 Qilu Pharmaceutical Quetiapine Fumarate API Product Portfolio
7.14.3 Qilu Pharmaceutical Quetiapine Fumarate API Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Qilu Pharmaceutical Main Business and Markets Served
7.14.5 Qilu Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Quetiapine Fumarate API Industry Chain Analysis
8.2 Quetiapine Fumarate API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Quetiapine Fumarate API Production Mode & Process
8.4 Quetiapine Fumarate API Sales and Marketing
8.4.1 Quetiapine Fumarate API Sales Channels
8.4.2 Quetiapine Fumarate API Distributors
8.5 Quetiapine Fumarate API Customers
9 Quetiapine Fumarate API Market Dynamics
9.1 Quetiapine Fumarate API Industry Trends
9.2 Quetiapine Fumarate API Market Drivers
9.3 Quetiapine Fumarate API Market Challenges
9.4 Quetiapine Fumarate API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
